Novozymes A/S

General ticker "NVZMF" information:

  • Sector: Materials
  • Industry: Chemicals - Specialty
  • Capitalization: $17.4B (TTM average)

Novozymes A/S follows the US Stock Market performance with the rate: 4.7%.

Estimated limits based on current volatility of 1.9%: low 60.65$, high 62.97$

Factors to consider:

  • Company pays dividends (irregularly): last record date 2025-08-22, amount 0.35$ (Y0.57%)
  • Price in estimated range
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [41.20$, 65.66$]
  • 2025-12-31 to 2026-12-31 estimated range: [40.77$, 65.08$]

Financial Metrics affecting the NVZMF estimates:

  • Negative: with PPE of 70.8 at the end of fiscal year the price was high
  • Positive: 7.61 < Operating profit margin, % of 13.07
  • Positive: Investing cash flow per share per price, % of -0.11 > -0.63
  • Positive: Return on assets ratio (scaled to [-100,100]) of 13.05 > 6.11
  • Positive: 0.14 < Industry earnings per price (median), % of 2.45
  • Positive: Shareholder equity ratio, % of 73.55 > 64.37
  • Positive: 2.99 < Industry operating profit margin (median), % of 5.52
  • Negative: Industry operating cash flow per share per price (median), % of 4.99 <= 5.48

Similar symbols

Short-term NVZMF quotes

Long-term NVZMF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue DKK17,905.94MM DKK28,590.09MM
Operating Expenses DKK13,928.50MM DKK24,853.65MM
Operating Income DKK3,977.44MM DKK3,736.44MM
Non-Operating Income DKK-66.34MM DKK-625.72MM
Interest Expense DKK23.24MM DKK76.40MM
R&D Expense DKK2,017.79MM DKK3,081.63MM
Income(Loss) DKK3,911.10MM DKK3,110.72MM
Taxes DKK870.62MM DKK830.07MM
Profit(Loss)* DKK3,025.57MM DKK305.80MM
Stockholders Equity DKK13,978.00MM DKK11,176.00MM
Inventory DKK3,627.00MM DKK720.60MM
Assets DKK28,391.00MM DKK15,195.60MM
Operating Cash Flow DKK4,152.00MM DKK1,019.90MM
Capital expenditure DKK2,056.00MM DKK359.80MM
Investing Cash Flow DKK-2,133.00MM DKK-199.70MM
Financing Cash Flow DKK-1,889.00MM DKK-703.20MM
Earnings Per Share** DKK10.89 DKK0.67

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.